Skip to main content

DESCIFRANDO LAS RESPUESTAS INDUCIDAS POR INTERFERON-ALFA DE LAS CELULAS ALFA Y BETA PANCREATICAS: UNA OPORTUNIDAD PARA BUSCAR NUEVAS DIANAS TERAPEUTICAS PARA LA DIABETES TIPO1

PID2020-117569RA-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Hyperglucagonemia and glucagon hypersecretion in early type 2 diabetes result from multifaceted dysregulation of pancreatic mouse α-cells

  • Ruiz-Pino, Antonia
  • Goncalves-Ramírez, Arianna
  • Jiménez-Palomares, Margarita
  • Merino, Beatriz
  • Castellano-Muñoz, Manuel
  • Vettorazzi, Jean F
  • Rafacho, Alex
  • Marroquí, Laura
  • Nadal, Ángel
  • Alonso-Magdalena, Paloma
  • Perdomo, Germán
  • Cózar-Castellano, Irene
  • Quesada, Iván
Hyperglucagonemia has been implicated in the pathogenesis of type 2 diabetes (T2D). In contrast to β-cells, studies on the function of the pancreatic α-cell in T2D are scarce. Consequently, the processes underlying hyperglucagonemia and α-cell dysfunction are largely unknown, limiting the appropriate design of specific pharmacological and therapeutic strategies. In the current study, we aimed to analyze the alterations of the pancreatic α-cell and its glucagon responses in diabetic db/db mice at early stages of the disease. In this context of glucose intolerance, hyperinsulinemia, and β-cell dysfunction, hyperglucagonemia was only present at fed conditions and was associated with insulin resistance. Yet, we found that the glucagon-to-insulin ratio in db/db mice did not change with fed or fasted states, further supporting that the metabolic regulation of glucagon release was impaired. Pancreatic β-cell dysfunction in db/db mice was manifested by increased basal secretion from isolated islets along with reduced insulin content. In contrast, α-cells from diabetic animals presented upregulated secretion and islet content of glucagon compared with controls. Electrophysiological analysis of dispersed α-cells revealed that altered secretion was not the result of impaired exocytosis. Instead, we found defective regulation of Ca2+ signaling by glucose. Besides these functional alterations, we also observed augmented α-cell mass in diabetic mice, which was accompanied by disrupted islet cytoarchitecture as well as increased α-cell size and number, without pieces of evidence of upregulated proliferation. Overall, these findings indicate that hyperglucagonemia in early T2D results from multifaceted α-cell deregulation in mice., This work was supported by grants from the Agencia Estatal de Investigación (PID2020-113112RB-I00, PID2020-117569RA-I00, PID2020-117294RB-I00, PID2022-136605OB-C21), and Generalitat Valenciana (PROMETEO/2020/006). CIBERDEM is an initiative of the Instituto de Salud Carlos III., Peer reviewed